Coronavirus / COVID

New model uses syndromic surveillance to predict admissions related to SARS-CoV-2.

The therapy is known to exhibit antiviral properties and reduce SARS-CoV-2 replication in laboratory studies.

Seqirus is seeking reactogenicity and immunogenicity outcomes between its influenza vaccines and available mRNA vaccines for COVID-19.

Plus: how could the COVID-19 testing market boom improve public flu awareness?

Recommendations based on local pollen levels may help manage infection risk.

As many vaccines are under Emergency Use Authorization (EUA), understanding the incidence rates of adverse events is critical to providing education and awareness, while working to increase distribution.

COVID-19 response restrained flu outbreaks last year. An expert explains his concern that won't be enough this winter.

A preview of our August 2021 issue Chairman’s Letter.

Delta Plus is very similar to the Delta variant with 1 additional mutation.

With a small number of heart-related adverse effects in younger people, the US Food and Drug Administration (FDA) will move towards a warning statement for Pfizer and Moderna vaccines.

A new report from a Qatari pilot program showed vaccines are highly effective against COVID-19, but they do not completely eliminate risk.

The benefits of mRNA vaccinations were determined to still clearly outweigh the risks in adolescents and young adults.

Because the number of children hospitalized with COVID-19 is so low, facilities should ensure clinical data is easily available and shared across healthcare platforms.

Children infected with SARS-CoV-2 who are Black, Hispanic or Asian have a greater risk of developing the rare multisystem inflammatory syndrome, a new study found.

An interview with a study author on unique associations between county infrastructures and COVID-19 fatality rates.

The device may help clinicians differentiate between past infections and co-infections during the upcoming flu season.

Greater disease severity was associated with low executive functioning.

According to a small study, the Moderna and Pfizer COVID-19 vaccines do not impact male fertility.

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.

The course of COVID-19 illness was likely to be less severe than of influenza in a study of hospitalized children.

New findings on an available 15-minute test show an approximate 81% sensitivity in detection of SARS-CoV-2.

New findings from the ASM 2021 World Microbe Forum suggest the emergency-authorized platform can capably detected the highly transmissible UK-borne variant.

Investigators looked at data from 3 analyses showed a reduction in mortality was observed across a spectrum of baseline oxygen requirements, at different timeframes, over the course of the pandemic, and in various geographies.

Africa sees third wave as only 1% of the population is fully vaccinated.

A study paired long-term care facilities (LTCF) staff who were recovered with susceptible residents to help reduce transmission. The goal was simple: pair those susceptible staff and residents with those who were recovered and felt to have protective immunity.

Modeling studies highlight best approaches for schools in the coming academic year.

CVnCoV demonstrated an interim vaccine efficacy of 47% against COVID-19 disease of any severity.

A discussion surrounding Novavax’s NVX-CoV2373 with Lisa Dunkle, MD.

Individuals with 3 or more comorbid conditions took longer for a negative SARS-CoV-2 PCR test result.

Multi-system inflammatory syndrome in children (MIS-C), is thought to affect 1 in 50,000 children with SARS-CoV-2 infection.